Does management of lipid lowering differ between specialists and primary care: Insights from GOAL Canada.

Langer, Anatoly; Tan, Mary; Goodman, Shaun G; Grégoire, Jean; Lin, Peter J; Mancini, G B John; Stone, James A; Leiter, Lawrence A

Langer, Anatoly; Tan, Mary; Goodman, Shaun G; Grégoire, Jean; Lin, Peter J; Mancini, G B John; Stone, James A; Leiter, Lawrence A.

Affiliation

Langer A; Canadian Heart Research Centre, North York, ON, Canada.
Tan M; Canadian Heart Research Centre, North York, ON, Canada.
Goodman SG; Canadian Heart Research Centre, North York, ON, Canada.
Grégoire J; St Michael's Hospital, University of Toronto, Toronto, ON, Canada.
Lin PJ; Institut de cardiologie de Montréal, Université de Montréal, Montréal, QC, Canada.
Mancini GBJ; Canadian Heart Research Centre, North York, ON, Canada.
Stone JA; University of British Columbia, Vancover, BC, Canada.
Leiter LA; Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Int J Clin Pract ; 75(4): e13861, 2021 Apr.

Article in En | MEDLINE | ID: mdl-33244861

Subject(s)

Anticholesteremic Agents; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Anticholesteremic Agents/therapeutic use; Canada; Cholesterol, LDL; Ezetimibe/therapeutic use; Female; Goals; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; Lipids; Middle Aged; Primary Health Care; Specialization; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Anticholesteremic Agents Type of study: Guideline Limits: Female / Humans / Middle aged Country/Region as subject: America do norte Language: En Journal: Int J Clin Pract Journal subject: MEDICINA Year: 2021 Document type: Article Affiliation country: Canada Country of publication: India

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google